(NDX1) Nordex SE - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000A0D6554
Stock: Wind Turbines, Installation, Maintenance, Monitoring
Total Rating 46
Risk 67
Buy Signal -0.77
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 41.0% |
| Relative Tail Risk | -3.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.54 |
| Alpha | 177.48 |
| Character TTM | |
|---|---|
| Beta | 0.078 |
| Beta Downside | 0.046 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.81% |
| CAGR/Max DD | 0.77 |
Description: NDX1 Nordex SE January 09, 2026
Nordex SE (XETRA:NDX1) designs, manufactures and sells multi-megawatt on-shore wind turbines and offers a suite of services-including project development, operation & maintenance, remote monitoring, and retrofit engineering-through its Projects and Services segments. Founded in 1985 and based in Hamburg, the group serves a global customer base across Europe, the Americas, and Asia-Pacific.
Key performance indicators that analysts watch include: (1) turbine installation backlog, which was €1.3 bn at end-2023, reflecting strong order flow; (2) average capacity factor of its installed fleet, currently around 45 %, indicating competitive turbine efficiency; and (3) EBIT margin, which has been pressured by rising raw-material costs but improved to 6.2 % in FY 2023 after cost-optimization initiatives. The sector is driven by the EU’s “Fit for 55” climate package and the global push for renewable-energy capacity additions, which together target an annual on-shore wind build-out of roughly 100 GW through 2030.
For a deeper, data-rich analysis of Nordex’s valuation dynamics, you may find the ValueRay platform’s proprietary metrics worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 108.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 3.68 > 1.0 |
| NWC/Revenue: 2.04% < 20% (prev -0.74%; Δ 2.78% < -1%) |
| CFO/TA 0.12 > 3% & CFO 702.8m > Net Income 108.1m |
| Net Debt (-828.7m) to EBITDA (450.0m): -1.84 < 3 |
| Current Ratio: 1.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (236.5m) vs 12m ago 1.84% < -2% |
| Gross Margin: 22.03% > 18% (prev 0.11%; Δ 2193 % > 0.5%) |
| Asset Turnover: 128.7% > 50% (prev 134.1%; Δ -5.32% > 0%) |
| Interest Coverage Ratio: 2.61 > 6 (EBITDA TTM 450.0m / Interest Expense TTM 105.1m) |
Altman Z'' 0.43
| A: 0.02 (Total Current Assets 3.82b - Total Current Liabilities 3.68b) / Total Assets 5.89b |
| B: -0.02 (Retained Earnings -106.3m / Total Assets 5.89b) |
| C: 0.05 (EBIT TTM 274.7m / Avg Total Assets 5.60b) |
| D: -0.01 (Book Value of Equity -32.2m / Total Liabilities 4.81b) |
| Altman-Z'' Score: 0.43 = B |
Beneish M -3.45
| DSRI: 1.17 (Receivables 1.19b/1.00b, Revenue 7.21b/7.12b) |
| GMI: 0.48 (GM 22.03% / 10.55%) |
| AQI: 1.01 (AQ_t 0.27 / AQ_t-1 0.27) |
| SGI: 1.01 (Revenue 7.21b / 7.12b) |
| TATA: -0.10 (NI 108.1m - CFO 702.8m) / TA 5.89b) |
| Beneish M-Score: -3.45 (Cap -4..+1) = AA |
What is the price of NDX1 shares?
As of February 07, 2026, the stock is trading at EUR 32.74 with a total of 344,551 shares traded.
Over the past week, the price has changed by -3.14%, over one month by +3.54%, over three months by +18.88% and over the past year by +183.95%.
Over the past week, the price has changed by -3.14%, over one month by +3.54%, over three months by +18.88% and over the past year by +183.95%.
Is NDX1 a buy, sell or hold?
Nordex SE has no consensus analysts rating.
What are the forecasts/targets for the NDX1 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.7 | -6.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 37.5 | 14.4% |
NDX1 Fundamental Data Overview February 03, 2026
Market Cap USD = 9.68b (8.20b EUR * 1.1801 EUR.USD)
P/E Trailing = 75.3913
P/E Forward = 29.6736
P/S = 1.1376
P/B = 7.4674
Revenue TTM = 7.21b EUR
EBIT TTM = 274.7m EUR
EBITDA TTM = 450.0m EUR
Long Term Debt = 266.2m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 146.4m EUR (from shortTermDebt, last quarter)
Debt = 549.3m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -828.7m EUR (from netDebt column, last quarter)
Enterprise Value = 7.37b EUR (8.20b + Debt 549.3m - CCE 1.38b)
Interest Coverage Ratio = 2.61 (Ebit TTM 274.7m / Interest Expense TTM 105.1m)
EV/FCF = 13.37x (Enterprise Value 7.37b / FCF TTM 551.4m)
FCF Yield = 7.48% (FCF TTM 551.4m / Enterprise Value 7.37b)
FCF Margin = 7.65% (FCF TTM 551.4m / Revenue TTM 7.21b)
Net Margin = 1.50% (Net Income TTM 108.1m / Revenue TTM 7.21b)
Gross Margin = 22.03% ((Revenue TTM 7.21b - Cost of Revenue TTM 5.62b) / Revenue TTM)
Gross Margin QoQ = 13.30% (prev 24.82%)
Tobins Q-Ratio = 1.25 (Enterprise Value 7.37b / Total Assets 5.89b)
Interest Expense / Debt = 3.73% (Interest Expense 20.5m / Debt 549.3m)
Taxrate = 36.04% (29.1m / 80.8m)
NOPAT = 175.7m (EBIT 274.7m * (1 - 36.04%))
Current Ratio = 1.04 (Total Current Assets 3.82b / Total Current Liabilities 3.68b)
Debt / Equity = 0.51 (Debt 549.3m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = -1.84 (Net Debt -828.7m / EBITDA 450.0m)
Debt / FCF = -1.50 (Net Debt -828.7m / FCF TTM 551.4m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.93% (Net Income 108.1m / Total Assets 5.89b)
RoE = 10.65% (Net Income TTM 108.1m / Total Stockholder Equity 1.02b)
RoCE = 21.43% (EBIT 274.7m / Capital Employed (Equity 1.02b + L.T.Debt 266.2m))
RoIC = 14.44% (NOPAT 175.7m / Invested Capital 1.22b)
WACC = 5.96% (E(8.20b)/V(8.75b) * Re(6.20%) + D(549.3m)/V(8.75b) * Rd(3.73%) * (1-Tc(0.36)))
Discount Rate = 6.20% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 86.89% ; FCFF base≈451.6m ; Y1≈491.0m ; Y5≈614.6m
Fair Price DCF = 78.81 (EV 17.81b - Net Debt -828.7m = Equity 18.63b / Shares 236.5m; r=5.96% [WACC]; 5y FCF grow 9.93% → 2.90% )
EPS Correlation: 87.86 | EPS CAGR: 211.2% | SUE: -4.0 | # QB: 0
Revenue Correlation: 54.74 | Revenue CAGR: 3.71% | SUE: -0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.10 | Chg30d=+0.029 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.32 | Chg30d=+0.064 | Revisions Net=+4 | Growth EPS=+27.2% | Growth Revenue=+9.7%
P/E Trailing = 75.3913
P/E Forward = 29.6736
P/S = 1.1376
P/B = 7.4674
Revenue TTM = 7.21b EUR
EBIT TTM = 274.7m EUR
EBITDA TTM = 450.0m EUR
Long Term Debt = 266.2m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 146.4m EUR (from shortTermDebt, last quarter)
Debt = 549.3m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -828.7m EUR (from netDebt column, last quarter)
Enterprise Value = 7.37b EUR (8.20b + Debt 549.3m - CCE 1.38b)
Interest Coverage Ratio = 2.61 (Ebit TTM 274.7m / Interest Expense TTM 105.1m)
EV/FCF = 13.37x (Enterprise Value 7.37b / FCF TTM 551.4m)
FCF Yield = 7.48% (FCF TTM 551.4m / Enterprise Value 7.37b)
FCF Margin = 7.65% (FCF TTM 551.4m / Revenue TTM 7.21b)
Net Margin = 1.50% (Net Income TTM 108.1m / Revenue TTM 7.21b)
Gross Margin = 22.03% ((Revenue TTM 7.21b - Cost of Revenue TTM 5.62b) / Revenue TTM)
Gross Margin QoQ = 13.30% (prev 24.82%)
Tobins Q-Ratio = 1.25 (Enterprise Value 7.37b / Total Assets 5.89b)
Interest Expense / Debt = 3.73% (Interest Expense 20.5m / Debt 549.3m)
Taxrate = 36.04% (29.1m / 80.8m)
NOPAT = 175.7m (EBIT 274.7m * (1 - 36.04%))
Current Ratio = 1.04 (Total Current Assets 3.82b / Total Current Liabilities 3.68b)
Debt / Equity = 0.51 (Debt 549.3m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = -1.84 (Net Debt -828.7m / EBITDA 450.0m)
Debt / FCF = -1.50 (Net Debt -828.7m / FCF TTM 551.4m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.93% (Net Income 108.1m / Total Assets 5.89b)
RoE = 10.65% (Net Income TTM 108.1m / Total Stockholder Equity 1.02b)
RoCE = 21.43% (EBIT 274.7m / Capital Employed (Equity 1.02b + L.T.Debt 266.2m))
RoIC = 14.44% (NOPAT 175.7m / Invested Capital 1.22b)
WACC = 5.96% (E(8.20b)/V(8.75b) * Re(6.20%) + D(549.3m)/V(8.75b) * Rd(3.73%) * (1-Tc(0.36)))
Discount Rate = 6.20% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 86.89% ; FCFF base≈451.6m ; Y1≈491.0m ; Y5≈614.6m
Fair Price DCF = 78.81 (EV 17.81b - Net Debt -828.7m = Equity 18.63b / Shares 236.5m; r=5.96% [WACC]; 5y FCF grow 9.93% → 2.90% )
EPS Correlation: 87.86 | EPS CAGR: 211.2% | SUE: -4.0 | # QB: 0
Revenue Correlation: 54.74 | Revenue CAGR: 3.71% | SUE: -0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.10 | Chg30d=+0.029 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.32 | Chg30d=+0.064 | Revisions Net=+4 | Growth EPS=+27.2% | Growth Revenue=+9.7%